Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SanaCutan Basiscreme is a corticoid-free topical cream primarily used as a supportive treatment for skin diseases such as eczema and dermatitis. It is designed for interval use alongside corticosteroid-containing ointments or creams, particularly in the management of acute or weeping skin conditions. The formulation contains emollient and moisturizing ingredients including white vaseline, viscous paraffin, cetylstearyl alcohol, ceteareth-20, glycerol 85%, potassium sorbate, sodium dihydrogen phosphate dihydrate, phosphoric acid, sorbic acid, and purified water. Its mechanism of action is to enhance skin barrier function and provide hydration; it does not contain active pharmaceutical ingredients with specific molecular targets but acts as an emollient to reduce dryness and subclinical inflammation. SanaCutan Basiscreme has been studied in clinical trials for atopic dermatitis (eczema), including pediatric populations. **Developer:** Infectopharm Arzneimittel **Supporting role:** Moisturizing and barrier protection in dermatological conditions such as eczema and dermatitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SanaCutan Basiscreme.